For Patients

Breast Cancer Patients

According to the World Health Organization, breast cancer is the most common cancer among women worldwide, affecting both developed and developing countries. Globally, nearly 1.7 million new breast cancer cases were diagnosed in 2012. Breast cancer is the second most common cancer in American women, and the risk that a woman in the United States will develop breast cancer in her lifetime is about 12%. Approximately 268,600 new cases of invasive breast cancer will be diagnosed each year in the US. For women recently diagnosed with breast cancer, the diagnosis carries with it a lot of fear and uncertainty. However, the community of breast cancer patients, caregivers, and survivors is strong, and there are many resources to help both patients and families deal with diagnoses and life with breast cancer. If you’ve been diagnosed with breast cancer, your physician is the best person to guide your treatment and care.

Patient Resources

Below are several resources that can provide useful information about prostate cancer and treatments.
Breastcancer.org
National Breast Cancer Foundation
The Cancer Support Community
Beyond the Shock
American Cancer Society
Susan G Komen

Clinical Trials

Arvinas is currently advancing ARV-471 toward clinical trials. ARV-471 is an orally-bioavailable PROTACĀ® protein degrader designed to target and degrade the estrogen receptor (ER) for the treatment of patients with locally-advanced or metastatic ER-positive / HER2-negative breast cancer. A Phase 1 clinical trial for ARV-471 in patients with locally-advanced or metastatic ER-positive / HER2-negative breast cancer is expected to begin in the third quarter of 2019 and preliminary clinical data is expected in 2020.